Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Jun 2;374(22):2183.
doi: 10.1056/NEJMc1602584.

CDX2 as a Prognostic Biomarker in Colon Cancer

Marta Schirripa  1 , Fotios Loupakis  2 , Heinz-Josef Lenz  3
Affiliations
Comment

CDX2 as a Prognostic Biomarker in Colon Cancer

Marta Schirripa et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this letter was reported.

Comment in

Comment on

  • CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
    Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, Wilcox-Fogel N, Forgó E, Rajendran PS, Miranda SP, Hisamori S, Hutchison J, Kalisky T, Qian D, Wolmark N, Fisher GA, van de Rijn M, Clarke MF. Dalerba P, et al. N Engl J Med. 2016 Jan 21;374(3):211-22. doi: 10.1056/NEJMoa1506597. N Engl J Med. 2016. PMID: 26789870 Free PMC article.

References

    1. Lugli A, Tzankov A, Zlobec I, Terracciano LM. Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. Mod Pathol 2008;21:1403–12. - PubMed
    1. Kim JH, Rhee YY, Bae JM, Cho NY, Kang GH. Loss of CDX2/ CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer. Am J Surg Pathol 2013;37:1532–41. - PubMed
    1. Landau MS, Kuan SF, Chiosea S, Pai RK. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immuno-histochemical expression. Hum Pathol 2014;45:1704–12. - PubMed
    1. Saridaki Z, Papadatos-Pastos D, Tzardi M, et al. BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome. Br J Cancer 2010;102:1762–8. - PMC - PubMed
    1. Souglakos J, Philips J, Wang R, et al. Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer 2009;101:465–72. - PMC - PubMed

LinkOut - more resources